Coin Bureau(@coinbureau):BREAKTHROUGH: AI reportedly played a major role in helping design Moderna’s personalized skin cancer vaccine, which has now succeeded in a Phase 3 trial. Moderna and Merck have developed a proprietary AI/ML-powered neoantigen-selection algorithm that helps identify up to 34 tumor mutations to target for each patient. Moderna then uses those targets to successfully create a personalised mRNA cancer vaccine.

Coin Bureau

@coinbureau

Official Coin Bureau X account: covering breaking news, insights & in-depth analysis across Fintech, Macro & AI.

加入 September 2017

431 正在關注 1.1M 粉絲

Coin Bureau@coinbureau

2026.08.20 02:47

BREAKTHROUGH: AI reportedly played a major role in helping design Moderna’s personalized skin cancer vaccine, which has now succeeded in a Phase 3 trial. Moderna and Merck have developed a proprietary AI/ML-powered neoantigen-selection algorithm that helps identify up to 34 tumor mutations to target for each patient. Moderna then uses those targets to successfully create a personalised mRNA cancer vaccine.